Track topics on Twitter Track topics that are important to you
Novogene has agreed to purchase 10 Pacific Biosciences (PacBio) Sequel ® System sequencers, allowing the buyer to double to 20 the number of Sequel systems it can run at any one time. Novogene is the world’s largest user of PacBio’s Sequel System, a nucleic acid sequencing platform launched in September 2015. Sequel System is designed to help researchers generate comprehensive de novo assemblies, and advance beyond fragmented draft genomes. Sequel System is based on PacBio’s unique Single Molecule, Real-Time ( SMRT ® ) technology and includes exceptionally long sequencing reads, uniform coverage, and a level of consensus accuracy that according to PacBio is the highest available. Sequel System delivers about 7X more reads with 1 million zero-mode waveguides (ZMWs) per SMRT Cell, PacBio says. Other features of the sequencing system include run-time flexibility ranging from 30 minutes to 10 hours per SMRT Cell, and run-size ...
Original Article: Seeing Double: Novogene Buys 10 More PacBio Sequel SystemsNEXT ARTICLE
DNA sequencing is the process of determining the precise order of nucleotides within a DNA molecule. During DNA sequencing, the bases of a small fragment of DNA are sequentially identified from signals emitted as each fragment is re-synthesized from a ...